How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?
Journal: Transfusion
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Bruneau L, Charlton CL, Ramirez-Arcos S, et al. (2026). "How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?". Transfusion. https://doi.org/10.1111/trf.70388